Molecular characterization of depression trait and state

Area of Science:

• Neuroscience
• Genomics
• Psychiatry

Background:

• Major depressive disorder (MDD) is a prevalent brain disorder with recurrent episodes and remissions.
• Understanding the molecular basis of MDD trait and state is crucial for targeted drug discovery.
• Current knowledge of biological alterations in MDD trait and state is limited.

Purpose of the Study:

• To differentiate molecular changes associated with MDD trait versus MDD state.
• To identify biological pathways and cellular alterations in MDD.
• To explore potential causal factors and therapeutic targets for MDD.

Main Methods:

• Transcriptomic profiling of postmortem subgenual anterior cingulate cortex from MDD patients (first episode, recurrent, and remission) and controls.
• Analysis of gene expression, biological pathways, and cell-specific molecular changes.
• Application of probabilistic Bayesian-network analysis to identify causal events.

Main Results:

• MDD trait associated with inflammation, immune activation, and reduced bioenergetics.
• MDD state linked to altered neuronal structure and reduced neurotransmission.
• Significant changes observed in specific GABAergic interneuron populations and causal roles identified for immune activation, cytokine response, and oxidative stress.

Conclusions:

• Distinct molecular pathologies characterize MDD trait and state.
• Identified plasticity mechanisms link trait and state pathologies in MDD.
• The study proposes a novel drug discovery approach targeting putative disease-causing pathways in MDD.